Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Meeting abstracts from the 9th International Conference on cGMP: Generators, Effectors and Therapeutic Implications.

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC6694467 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Meeting abstracts from the 9th International Conference on cGMP: Generators, Effectors and Therapeutic Implications.

Journal of translational medicine 20190815 Suppl 2

PMID: 31412886

Similar Datasets

Meeting abstracts from the 10th International Conference on cGMP: Generators, Effectors and Therapeutic Implications.

Project description: Not available

| S-EPMC9887734 | biostudies-literature

Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications : Bamberg, Germany. 23-25 June, 2017.

Project description: Not available

| S-EPMC5667593 | biostudies-literature

Meeting report of the 8<sup>th</sup> International Conference on cGMP "cGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017.

Project description:Although the Nobel Prize for the discovery of nitric oxide (NO) dates back almost 20 years now, the knowledge about cGMP signaling is still constantly increasing. It looks even so that our understanding of the role of the soluble guanylyl cyclase (sGC) and particulate guanylyl cyclase (pGC) in health and disease is in many aspects at the beginning and far from being understood. This holds even true for the therapeutic impact of innovative drugs acting on both the NO/sGC and the pGC pathways. Since cGMP, as second messenger, is involved in the pathogenesis of numerous diseases within the cardiovascular, pulmonary, renal, and endocrine systems and also plays a role in neuronal, sensory, and tumor processes, drug applications might be quite broad. On the 8th International Conference on cGMP, held in Bamberg, Germany, world leading experts came together to discuss these topics. All aspects of cGMP research from the basic understanding of cGMP signaling to clinical applicability were discussed in depth. In addition, present and future therapeutic applications of cGMP-modulating pharmacotherapy were presented ( http://www.cyclicgmp.net/index.html ).

| S-EPMC5783999 | biostudies-literature

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.

Project description:Increasing cGMP is a unique therapeutic principle, and drugs inhibiting cGMP-degrading enzymes or stimulating cGMP production are approved for the treatment of various diseases such as erectile dysfunction, coronary artery disease, pulmonary hypertension, chronic heart failure, irritable bowel syndrome, or achondroplasia. In addition, cGMP-increasing therapies are preclinically profiled or in clinical development for quite a broad set of additional indications, e.g., neurodegenerative diseases or different forms of dementias, bone formation disorders, underlining the pivotal role of cGMP signaling pathways. The fundamental understanding of the signaling mediated by nitric oxide-sensitive (soluble) guanylyl cyclase and membrane-associated receptor (particulate) guanylyl cyclase at the molecular and cellular levels, as well as in vivo, especially in disease models, is a key prerequisite to fully exploit treatment opportunities and potential risks that could be associated with an excessive increase in cGMP. Furthermore, human genetic data and the clinical effects of cGMP-increasing drugs allow back-translation into basic research to further learn about signaling and treatment opportunities. The biannual international cGMP conference, launched nearly 20 years ago, brings all these aspects together as an established and important forum for all topics from basic science to clinical research and pivotal clinical trials. This review summarizes the contributions to the "10th cGMP Conference on cGMP Generators, Effectors and Therapeutic Implications," which was held in Augsburg in 2022 but will also provide an overview of recent key achievements and activities in the field of cGMP research.

| S-EPMC10338386 | biostudies-literature

Abstracts from the 9th International Conference for Healthcare and Medical Students (ICHAMS) : Dublin, Ireland. 6-8 February 2020

Project description: Not available

| S-EPMC7191674 | biostudies-literature

Abstracts of the 9th International Conference on Cachexia, Sarcopenia, and Muscle Wasting, Berlin, Germany, 10–11 December 2016 (part 2)

Project description: Not available

| S-EPMC5326821 | biostudies-literature

Oral abstracts of the 21st International AIDS Conference.

Project description: Not available

| S-EPMC5625587 | biostudies-literature

Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2022".

Project description: Not available

| S-EPMC10337046 | biostudies-literature

Meeting report: 32nd International Conference on Antiviral Research.

Project description:The 32nd International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held in Baltimore, Maryland, USA, on May 12-15, 2019. This report gives an overview of the conference on behalf of the Society. It provides a general review of the meeting and awardees, summarizing the presentations, and their main conclusions from the perspective of researchers active in many different areas of antiviral research and development. As in past years, ICAR promoted and showcased the most recent progress in antiviral research, and continued to foster collaborations and interactions in drug discovery and development. The 33rd ICAR will be held in Seattle, Washington, USA, March 30th-April 3rd, 2020.

| S-EPMC7105345 | biostudies-literature

Meeting Abstracts from the 8th Annual Atlantic Corridor Medical Student Research Conference.

Project description: Not available

| S-EPMC10191678 | biostudies-literature